Effect of Behavioral Economic Incentives for Colorectal Cancer Screening in a Randomized Trial is a research paper published in Clinical Gastroenterology and Hepatology (2020). On theSindex it has a DataRank of 0.849. It has been cited 19 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.400
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
University of Pennsylvania
Grant: K08CA234326
NCATS NIH HHS
Grant: UL1 TR001878
National Cancer Institute
Institute for Translational Medicine and Therapeutics
National Center for Advancing Translational Sciences
Hawaii Medical Service Association
National Institutes of Health
FWCI
0.61
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system
Additional file 1 of Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system
Additional file 2 of Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system
Additional file 2 of Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system